Stockscreener 앱 받기
16.41
6.25%
-1.095
전일 마감가:
$17.51
열려 있는:
$17
하루 거래량:
136.06K
Relative Volume:
0.27
시가총액:
$307.16M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-8.19%
1개월 성능:
+7.71%
6개월 성능:
-24.51%
1년 성능:
-60.80%
1일 변동 폭
$16.37
$17.50
1주일 범위
$16.37
$26.00
52주 변동 폭
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
명칭
Tectonic Therapeutic Inc
전화
(339) 666-3320
주소
490 ARSENAL WAY, WATERTOWN
TECX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
16.41 | 327.65M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.02 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.23 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.09 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.63 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.03 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-09-03 | 개시 | Oppenheimer | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-06-11 | 재개 | Raymond James | Outperform |
| 2025-04-21 | 개시 | Mizuho | Outperform |
| 2024-11-20 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-06-24 | 개시 | TD Cowen | Buy |
| 2023-12-18 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-05 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-27 | 개시 | Needham | Buy |
| 2021-03-09 | 개시 | Barclays | Overweight |
| 2021-03-02 | 개시 | Stifel | Hold |
| 2020-11-11 | 개시 | Berenberg | Buy |
| 2020-03-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 개시 | Mizuho | Buy |
| 2019-04-05 | 개시 | Janney | Buy |
| 2018-10-10 | 개시 | Guggenheim | Buy |
| 2018-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-17 | 개시 | H.C. Wainwright | Buy |
| 2018-07-16 | 개시 | Wedbush | Outperform |
| 2018-07-16 | 개시 | Wells Fargo | Outperform |
모두보기
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Price action breakdown for Tectonic Therapeutic Inc.July 2025 Levels & Safe Capital Investment Plans - newser.com
Chart based analysis of Tectonic Therapeutic Inc. trendsMarket Movers & Safe Entry Point Alerts - newser.com
Tools to monitor Tectonic Therapeutic Inc. recovery probabilityQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
How high can Tectonic Therapeutic Inc. stock go2025 EndofYear Setup & Low Risk High Reward Ideas - newser.com
What institutional flow reveals about Tectonic Therapeutic Inc.Earnings Growth Summary & Weekly Chart Analysis and Guides - newser.com
It is Poised to be a Bull Market for Tectonic Therapeutic Inc (TECX) - setenews.com
Tectonic Therapeutic Inc expected to post a loss of $1.05 a shareEarnings Preview - TradingView
Is Tectonic Therapeutic Inc. meeting your algorithmic filter criteriaMarket Risk Report & Weekly High Return Stock Opportunities - newser.com
How to track smart money flows in Tectonic Therapeutic Inc.Earnings Miss & Expert Verified Movement Alerts - newser.com
Can Tectonic Therapeutic Inc. stock sustain market leadershipWeekly Stock Recap & Weekly Setup with ROI Potential - newser.com
What data driven models say about Tectonic Therapeutic Inc.’s futureJuly 2025 Short Interest & Verified High Yield Trade Plans - newser.com
Is Tectonic Therapeutic Inc. stock attractive for retirement portfoliosJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com
Truist Financial Sticks to Its Buy Rating for Tectonic Therapeutic (TECX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Tectonic Therapeutic (TECX) and Akebia Therapeutics (AKBA) - The Globe and Mail
Is Tectonic Therapeutic Inc. forming a reversal patternQuarterly Profit Review & Risk Adjusted Buy and Sell Alerts - newser.com
Tectonic Therapeutic (TECX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
What recovery options are there for Tectonic Therapeutic Inc.July 2025 Setups & Entry and Exit Point Strategies - newser.com
Transcript : Tectonic Therapeutic, Inc.Special Call - MarketScreener
Can Tectonic Therapeutic Inc. stock deliver consistent earnings growth2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Tectonic Therapeutics stock maintains Outperform rating at Oppenheimer By Investing.com - Investing.com Nigeria
Tectonic Therapeutic Reports Positive Phase 1b Trial Results - TipRanks
Tectonic Therapeutics stock maintains Outperform rating at Oppenheimer - Investing.com
Tectonic Therapeutic, Inc. Announces Positive Results from TX45 Phase 1b Part B Trial - TradingView
Why Tectonic Therapeutic Stock Soared 30% After-Hours Today - Asianet Newsable
Tectonic surges on phase 1b data for pulmonary hypertension asset - Seeking Alpha
Tectonic Therapeutic stock soars after positive Phase 1b data for heart failure drug - Investing.com Canada
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF - The Manila Times
Tectonic (NASDAQ: TECX) reports -29.2% PCWP, +17.3% CO with TX45 in PH‑HFrEF Phase 1b - Stock Titan
Tectonic Therapeutic Inc (TECX) 재무 분석
Tectonic Therapeutic Inc (TECX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.71%
0.18%
자본화:
|
볼륨(24시간):